DekaBank Deutsche Girozentrale’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-14,300
| Closed | -$1.54M | – | 1350 |
|
2023
Q1 | $1.54M | Hold |
14,300
| – | – | ﹤0.01% | 776 |
|
2022
Q4 | $1.57M | Hold |
14,300
| – | – | ﹤0.01% | 777 |
|
2022
Q3 | $832K | Hold |
14,300
| – | – | ﹤0.01% | 919 |
|
2022
Q2 | $398K | Hold |
14,300
| – | – | ﹤0.01% | 1062 |
|
2022
Q1 | $537K | Buy |
14,300
+1,300
| +10% | +$48.8K | ﹤0.01% | 1048 |
|
2021
Q4 | $489K | Buy |
+13,000
| New | +$489K | ﹤0.01% | 1100 |
|